Proteinuria

Type: Keyphrase
Name: Proteinuria
First reported 2 hours ago - Updated 1 hour ago - 4 reports

Clinical Trial Results Indicate Acthar May Significantly Reduce Proteinuria in Patients with Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy

Clinical Trial Results Indicate Acthar May Significantly Reduce Proteinuria in Patients with Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy ... [Published Noodls - 1 hour ago]
First reported 5 hours ago - Updated 5 hours ago - 1 reports

NOXXON announces encouraging data from Phase IIa diabetic nephropathy trial

NOXXON Pharma AG, a biopharmaceutical company, has announced Phase IIa proof-of-concept data from the emapticap pegol trial in patients with diabetic nephropathy. Emapticap pegol is a Spiegelmer that binds and neutralizes CCL2/MCP-1 (C-C Chemokine Ligand ... [Published Individual.com - 5 hours ago]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

How To Stop Kidney Disease Damage With Nutrition and Diet Tip

http://www.healkidneydisease.com This video is about how to stop kidney disease damage with a diet tip of avoiding salt. This nutrition tip for kidney disease was shown in a study to cut down on proteinuria which in turn will stop any further kidney disease ... [Published StreetFire Video Network - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Study Results from Virginia Tech Broaden Understanding of Veterinary Medicine

By a News Reporter-Staff News Editor at Veterinary Week -- Investigators discuss new findings in Veterinary Medicine. According to news reporting originating from Blacksburg, Virginia , by VerticalNews correspondents, research stated, "The prevalence ... [Published 4 Traders - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

QUIDEL : Patent Issued for Methods of Use for an Immunoassay Detecting Fragment Ba

By a News Reporter-Staff News Editor at Diabetes Week -- Quidel Corporation ( San Diego, CA ) has been issued patent number 8691513, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also Quidel Corporation ... [Published 4 Traders - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Issue Summary April 15, 2014

issue, including articles on U.S. trends in prevalence and control of diabetes, quantifying delirium severity, virtual autopsy versus traditional medical autopsy, high-energy extracorporeal shock-wave therapy for shoulder tendinitis, and point-of-care ... [Published Annals of Internal Medicine - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Atrasentan could be additional drug treatment for diabetic kidney disease

A Dutch study shows the drug atrasentan offers benefits as an add-on treatment for diabetic nephropathy in addition to blood pressure medications such as ACE inhibitors and AIIRAs.Researchers from the University Medical Centre Groningen reviewed patients ... [Published Diabetes.co.uk - Apr 14 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Drug Beneficial to Diabetics with Kidney Disease

(Ivanhoe Newswire) – A drug called atrasentan provides health benefits for patients with both diabetes and kidney disease, according to a new study. The findings suggest atrasentan may help maintain the well-being of patients who are at high risk of experiencing ... [Published Medical Breakthroughs - Apr 14 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 3 reports

Atrasentan lowered albuminuria BP for patients with type 2 diabetes

Patients with type 2 diabetic nephropathy already receiving treatment to reduce albuminuria and improve blood pressure could cut the risks for kidney and cardiovascular disease with treatments of atrasentan, according to data published in the Journal ... [Published Orthopedics Today - Apr 10 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Post-partum trend in blood pressure levels, renal function and proteinuria in women with severe ...

Preeclampsia and eclampsia, which are the most frequent hypertensive disorders in pregnancy, are associated with renal involvements. We aimed to assess the time trend in blood pressure levels, renal function and proteinuria after delivery, and investigate ... [Published 7thSpace - Apr 09 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Microalbuminuria as a Risk Predictor in Diabetes

Keen H, Chlouverakis C. Urinary albumin excretion and diabetes mellitus. Lancet 1964;2:1155–1156Keen H, Chlouverakis C, Fuller J, Jarrett RJ. The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, ... [Published General Medicine eJournal - Apr 08 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

Simplified Microchip Electrophoresis Rapidly Separates Urinary Proteins

Image: Conventional Agarose Gel Electrophoresis for proteins (Photo courtesy of Helena).A urine protein test is to detect the presence of protein in a person's urine, while in healthy individuals, there is only very low concentration of protein in urine, ... [Published Lab Medica - Mar 27 2014]

Quotes

...Acthar in the treatment of patients suffering from idiopathic types of nephrotic syndrome," said Steve Cartt, Chief Operating Officer of Questcor. "As a company, we continue to actively support both company-sponsored research and independent academic research evaluating Acthar in on-label indications such as the one studied in this trial, as well as in other autoimmune and inflammatory disorders having high unmet medical need."
... With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the possibility of developing other on-label indications and the possibility of pursuing FDA approval of additional indications...
...of Medicine and Director of the ASH Comprehensive Hypertension Center at the University of ChicagoUniversity of Chicago Medicine remarked: "From the data I've seen, I'm particularly impressed by the dissociation of emapticap pegol's albuminuria lowering effect from hemodynamics. The fact that this beneficial effect is accompanied by an additional benefit on glycemic control is a unique feature that differentiates this drug from other compounds in development."
According to the news editors, the research concluded: "This, together with the atherosclerotic burden and endothelial dysfunction, suggests that there is a physiopathologic relationship between macrovascular and microvascular impairment."

More Content

All (126) | News (118) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Clinical Trial Results Indicate Acthar May Sign... [Published Noodls - 1 hour ago]
Clinical Trial Results Indicate Acthar May Sign... [Published Nasdaq - 2 hours ago]
Clinical Trial Results Indicate Acthar May Sign... [Published ADVFN India - 2 hours ago]
Clinical Trial Results Indicate Acthar May Sign... [Published PR Newswire: Health - 2 hours ago]
NOXXON announces encouraging data from Phase II... [Published Individual.com - 5 hours ago]
Benefits of ARBs Not the Same as ACE Inhibitors [Published Diabetes in Control - Apr 19 2014]
How To Stop Kidney Disease Damage With Nutritio... [Published StreetFire Video Network - Apr 18 2014]
Recent Findings from University of Girona Provi... [Published NewsRX - Apr 18 2014]
Study Results from Virginia Tech Broaden Unders... [Published 4 Traders - Apr 17 2014]
Recent Studies from University of Barcelona Add... [Published 4 Traders - Apr 17 2014]
New Findings in Amyloidosis Described from Shin... [Published 4 Traders - Apr 16 2014]
Studies Conducted at Veterans Affairs Medical C... [Published 4 Traders - Apr 16 2014]
QUIDEL : Patent Issued for Methods of Use for a... [Published 4 Traders - Apr 16 2014]
Effects of Allopurinol on Endothelial Dysfuncti... [Published Sexual Development - Apr 16 2014]
Hyperuricemia and deterioration of renal functi... [Published 7thSpace - Apr 16 2014]
Degrees of Kidney Disease in Nigerian Adults wi... [Published Sexual Development - Apr 15 2014]
Issue Summary April 15, 2014 [Published Annals of Internal Medicine - Apr 15 2014]
Atrasentan could be additional drug treatment f... [Published Diabetes.co.uk - Apr 14 2014]
Drug Beneficial to Diabetics with Kidney Disease [Published Medical Breakthroughs - Apr 14 2014]
Researchers at Wake Forest University Release N... [Published NewsRX - Apr 12 2014]
Systolic Blood Pressure and Outcomes in Stage 3... [Published American Journal of Hypertension - Apr 12 2014]
Umbilical cord stem cell transplantation produc... [Published Orthopedics Today - Apr 12 2014]
GSK-3β and Vitamin D Receptor are Involved in β... [Published Sexual Development - Apr 12 2014]
The Impact of Blood Pressure on Kidney Function... [Published Sexual Development - Apr 11 2014]
Atrasentan May Work in Diabetic Kidney Disease ... [Published MedPageToday.com - medical news plus CME for ph ... - Apr 11 2014]
Atrasentan lowered albuminuria BP for patients ... [Published Orthopedics Today - Apr 10 2014]
Drug Provides Health Benefits to Diabetics with... [Published Newswise - Apr 10 2014]
Drug provides health benefits to diabetics with... [Published Medical Xpress - Apr 10 2014]
Task Force Recommends Low-Dose Aspirin for Wome... [Published PT Community - Apr 09 2014]
Avastin Plus Chemotherapy Improves Progression-... [Published CancerConnect.com - Apr 09 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Clinical Trial Results Indicate Acthar May Sign... [Published PR Newswire: Health - 2 hours ago]
ANAHEIM, Calif., April 21, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that results from an investigator-initiated clinical study involving two major academic research centers examining the dosing and effectiveness ...
Atrasentan May Work in Diabetic Kidney Disease ... [Published MedPageToday.com - medical news plus CME for ph ... - Apr 11 2014]
(MedPage Today) -- Adding the endothelin receptor antagonist atrasentan to renin-angiotensin blockade reduced albuminuria without major side effects in patients with diabetic nephropathy, researchers found. ...
NOXXON Presents Positive Results from Emapticap... [Published Business Wire Health News - Apr 04 2014]
BERLIN--(BUSINESS WIRE)--NOXXON presents positive results from emapticap pegol phase IIa diabetic nephropathy study:anti-CCL2 /MCP-1 Spiegelmer NOX-E36 shows beneficial and lasting effects on albuminuria and glycemic control. ...
Research and Markets: Proteinuria - Pipeline Re... [Published Business Wire Professional Services News - Feb 18 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/c8b8dp/proteinuria) has announced the addition of the "Proteinuria - Pipeline Review, H2 2013" report to their offering. 'Proteinuria - Pipeline Review, H2 2013', ...
What is killing young Central American men? [Published H5N1 - Feb 14 2014]
Via PLOS Speaking of Medicine blog, a fascinating post: Tropical Medicine Mystery: Something is Killing Young Men in Central America. Excerpt:Over the last decade drug trafficking and violence have taken the lives of thousands of people, most of them ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.